Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Benatar

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2022
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approachesCorey T McMillan, Joanne Wuu, Katya Rascovsky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Ebiomedicine|September 13, 2024
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Eric A Macklin, Andrea Malaspina, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 8, 2012
Electrical impedance myography as a biomarker to assess ALS progressionSeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2025
ALSUntangled #79: alpha-lipoic acidAlaina Giacobbe, James Hiana, Olivia Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 18, 2022
ALSUntangled #68: ozone therapyYuyao Sun, Paul Barkhaus, Benjamin Barnes, et al.
Annals of Neurology|June 20, 2017
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosisTania F Gendron, , Lillian M Daughrity, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 25, 2023
ALSUntangled # 69: astaxanthinTimothy Fullam, Carmel Armon, Paul Barkhaus, et al.
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 7, 2022
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approachesCorey T McMillan, Joanne Wuu, Katya Rascovsky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2024
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTDMichael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, et al.
Ebiomedicine|September 13, 2024
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Eric A Macklin, Andrea Malaspina, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 8, 2012
Electrical impedance myography as a biomarker to assess ALS progressionSeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2025
ALSUntangled #79: alpha-lipoic acidAlaina Giacobbe, James Hiana, Olivia Wang, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 18, 2022
ALSUntangled #68: ozone therapyYuyao Sun, Paul Barkhaus, Benjamin Barnes, et al.
Annals of Neurology|June 20, 2017
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosisTania F Gendron, , Lillian M Daughrity, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 25, 2023
ALSUntangled # 69: astaxanthinTimothy Fullam, Carmel Armon, Paul Barkhaus, et al.
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Pageof 25